rs of the convention. Along with Stryker and Zimmer Biomet, the Mexican agency has pursued three other healthcare companies: Olympus Latin America, Fresenius and Teva Pharmaceuticals. The latter three complaints were filed last year. The case against Olympus is pending, while the Fresenius case has been m

y had brought results. Since February 2018, one woman and two non-white men have been appointed monitors in three ongoing FCPA settlements. They are Fresenius monitor Erin Sloane of WilmerHale; Panasonics Avionics monitor Manley of Paul Hastings; and Mobile TeleSystems monitor Leonard McCarthy of LFMcCarth

an, Patrice Caine as CEO says AFP (trading -1.1%) • Kingfisher to sell controlling stake in B&Q China for £140 million to Wumei (trading +1.7%) • Fresenius being sued by Sanofi to block generic Jevtana prostate-cancer drug (trading +1.1%) • Bilfinger sells construction unit to Implenia, expects roughly

driven by developed markets, no change in outlook (trading -3.5%) Morrisons 01 sales broadly in line, outlook remains challenging (trading -0.60%) Fresenius and Fresenius Medical Q1's in line with pre announcement last week (trading +1.7%) PagesJaunes Q1 sales inline with estimates, net misses, confirms

ts key macro themes for 2014) • Barclays said to plan "role-based pay" for some employees to counter EU bonus caps (Bloomberg) (trading +0.54%) • Fresenius: US scraps medicare cuts, keeps 2014/15 dialysis bundles flat & allow for inflation adjusters (trading +8.4%) • Babcock & Avincis Mission (helicopt

, BAT, Bovis Homes, Carrefour - Financials: Aroundtown Properties, AXA, Banco Santander, Credit Suisse Group, Prudential - Healthcare: AstraZeneca, Fresenius, Shire Energy, Materials & Industrials: ABB, ArcelorMittal, BAE, Continental, DSM, Glencore, Kingspan, Linde, Renault, Royal Dutch Shell, RWE - TM

ge 17 - Page 18 B&M BAT Bovis Homes Carrefour - SELL Aroundtown Properties AXA Banco Santander Credit Suisse Group Prudential AstraZeneca Fresenius Shire ■ Energy, Materials & Industrials - Page 20 ABB Page 21 ArcelorMittal Page 22 BAE Page 23 Continental ■ Energy, Materials & Industrials

> Healthcare Deutsche Bank 41) Fresenius — Gunnar Romer, BUY, close €65.4, €83 tgt, 27% upside s Strong outlook - we expect defensive low-teens EPS growth to 2020, given sound end market d

er growth, strong uptake of 3D and Ultra HD, unexpectedly strong demand from military and governmental organisations, lower-than-expected CAPEX. ■ Fresenius - FREG.DE: General downside risks relate to healthcare reform and austerity with negative consequences for Fresenius. Company specific downside ris

oports de Paris ADP.PA ExxonMobil XOM.N Renault SA RE NA. PA Air Berlin PLC AB1.DE Fortinet Inc FTNT.OQ Roche ROG.S ArcelorMittal MT.AS Fresenius FREG.DE Royal Dutch Shell Plc RDSa.L Aroundtown Properties AT1.DE Geberit GEBN.S Royal Mail RMG.L AstraZeneca AZN.L Glencore GLEN.L RWE